Yuet Wai Kan's Pioneering Work in Prenatal DNA Screening for Genetic Blood Disorders
By
Lasker Admin
Summary
The article discusses Lasker Laureate Yuet Wai Kan's pioneering work in developing prenatal DNA-based screening tests for blood disorders like sickle cell anemia and thalassemia, two of the most common genetic diseases worldwide. These conditions stem from defects in hemoglobin-producing genes. Kan's foundational research also enabled subsequent progress in identifying additional genetic diseases and advancing prenatal genetic testing.
Source
bskyYuet Wai Kan's Pioneering Work in Prenatal DNA Screening for Genetic Blood Disorderslaskerfoundation.orgKey quotes
· 3 pulledLasker Laureate Yuet Wai Kan pioneered the design and implementation of prenatal DNA-based screening tests for blood disorders such as sickle cell anemia and thalassemia
These conditions are caused by defects in genes that help make hemoglobin
Kan also helped lay the groundwork for subsequent progress in the identification of additional genetic diseases and in prenatal
You might also wanna read
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra
cuimc.columbia.edu·9mo ago
WHO publishes first global guidelines for managing sickle-cell disease in children and adolescents
This article presents the first WHO normative guideline on the diagnosis, prevention, and clinical management of sickle-cell disease (SCD) i
bit.ly·2d agoA new blood type discovered in France: "Gwada negative", a global exception
The Evolution of DNA Sequencing: From Sanger to Nanopore Technology
This article provides a comprehensive visual guide to DNA sequencing technologies, tracing the evolution from the Human Genome Project's ini
asimov.press·3mo ago
FDA Approves First Dual-AAV Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program
The FDA has approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy for trea
FDA·1mo ago
First Successful In-Utero Stem Cell Therapy for Spina Bifida Shows Safety in Phase 1 Trial
UC Davis Health researchers have successfully performed the world's first in-utero stem cell therapy for spina bifida repair, combining feta
health.ucdavis.edu·3mo ago